THE LATEST WORD

Top Industry News – February 28, 2012

Posted on February 28th, 2012 | by Rxmedyn | No Comments »

Americans Get Reacquainted With IUDs

Stem Cells Turned Into Eggs

Fake Avastin Had Salt, Starch, Chemicals: Roche

Medical Tattoos Offer Important Health Information

FDA Device Chief Says Approval ‘Loophole’ Needs Closing

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 24, 2012

Posted on February 24th, 2012 | by Rxmedyn | No Comments »

F.D.A. Lists Sources of Tainted Drug

FDA Advisory Panel Backs Vivus’s Qnexa

Seven States File Lawsuits Over Contraception Rule

Hepatitis C Killing More Americans Than HIV

US Drafts Plan To Fight Feared Alzheimer’s Disease

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 21, 2012

Posted on February 21st, 2012 | by Rxmedyn | No Comments »

Research: Aspirin Shows Promise in Limiting Cancer for Women Who Have H.I.V., Scientists Say

Microchip Implanted to Deliver Drug Shows Promise in Trial

Red Flags Ignored, DEA Says

Daily Diet Soda May Increase Risk Of Heart Attack, Stroke: Study

Hepatitis C Deaths Up, Baby Boomers Most At Risk

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 17, 2012

Posted on February 17th, 2012 | by Rxmedyn | No Comments »

Obama Shift on Providing Contraception Splits Critics

Counterfeit Doses of Avastin Distributed in the U.S.

Remote-Controlled Chip Implant Delivers Bone Drug

Antibiotics No Help Against Most Sinus Infections: Study

Alzheimer’s: Trouble Sleeping Could Affect Memory Later On, Study Finds

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 14, 2012

Posted on February 14th, 2012 | by Rxmedyn | No Comments »

The Freedom to Choose Birth Control

Supply of a Cancer Drug May Run Out Within Weeks

New Drug Approved to Treat Glaucoma

Obama Asks For Hike In Industry Funding For FDA

‘Hunger Hormone’ Could Help Chemo Patients: Study

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 10, 2012

Posted on February 10th, 2012 | by Rxmedyn | No Comments »

FDA Panel Votes Against Expanding Use of Amgen Drug Xgeva

Suit Wants ‘Morning-After Pill’ Available To Girls

For Pregnant Women With Cancer, Chemo Possible

Advisory Committee Set To Review Cardiovascular Risk Assessment For Obesity Drugs

First U.S. Cell-Based Flu Vaccine Plant Awaits Pandemic

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 7, 2012

Posted on February 7th, 2012 | by Rxmedyn | No Comments »

Texans Lead Battle for Women’s Health

A.M. Vitals: Merck Will Apply for Suvorexant Approval This Year

Government Health Spending Seen Hitting $1.8 Trillion

Too Many Kids Breathe Others’ Smoke In Cars: CDC

Pfizer’s Breast-Cancer Drug Worsens Bone Loss in Older Women

Read the rest of this entry »

Posted in Industry Stories

Top Industry News – February 3, 2012

Posted on February 3rd, 2012 | by Rxmedyn | No Comments »

Breast Cancer Surgery Rules Are Called Unclear

New Vaccine Recommendations for Boys and Diabetics

Pfizer Cites Packaging Flaws in Birth-Control Pill Recall

Breastfeeding Tied To Stronger Lungs, Less Asthma

Komen Drops Plan to Cut Planned Parenthood Grants

Read the rest of this entry »

Posted in Industry Stories